Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 0.42 |
| ▸ | PYGL | P06737 | 3/20 | 0.41 |
| ▸ | PYGM | P11217 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.34 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29836760 | 0.84 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL18385978 | 0.84 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL8507620 | 0.84 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL16259329 | 0.78 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL8585884 | 0.78 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL5703493 | 0.78 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL28265605 | 0.78 | PYGB (0.41) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL30015863 | 0.77 | MEN1 (0.54) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL7157539 | 0.77 | MEN1 (0.54) | PYGBPYGLPYGMMEN1KMT2A | |
| SCHEMBL2785358 | 0.77 | MEN1 (0.54) | PYGBPYGLPYGMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1853217-B1 | HAIRCARE USE OF C-GLYCOSIDE DERIVATIVES | OREAL (FR) | 2009-04-01 | — | — | EP | disclosed |
| US-20080153760-A1 | Haircare Use Of C-Glycoside Derivatives | L'OREAL (FR) | 2008-06-26 | — | — | US | disclosed |
| EP-1853217-A1 | HAIRCARE USE OF C-GLYCOSIDE DERIVATIVES | L'Oréal (FR) | 2007-11-14 | — | — | EP | disclosed |
| WO-2006090307-A1 | HAIRCARE USE OF C-GLYCOSIDE DERIVATIVES | L'OREAL (FR) | 2006-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153760-A1 | Haircare Use Of C-Glycoside Derivatives | KRT18, CD44, FGF1 | PYGB 3968/4885PYGL 3124/4885PYGM 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.